D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial

Autor: Rebecchi, F., Garino, M., Vigano, L., Scaglione, D., Locatelli, L., Mello Teggia, P., Degiuli, M., Reddavid, R., Tomatis, M., Ponti, A., Morino, M., Sasako, M.
Zdroj: In European Journal of Cancer June 2021 150:10-22
Databáze: ScienceDirect